Home LiteratureArticle Details
PMID: 18248624 Published · ppublish English Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Parkin mediates the degradation-independent ubiquitination of Hsp70.

Journal of neurochemistry ·Vol. 105 ·No. 5 ·2008-06-00 ·Pages 1806-19

Moore DJ, West AB, Dikeman DA, Dawson VL, Dawson TM

Abstract

Mutations in the parkin gene cause autosomal recessive, juvenile-onset parkinsonism. Parkin is an E3 ubiquitin ligase that mediates the ubiquitination of protein substrates. Disease-associated mutations cause a loss-of-function of parkin which may compromise the poly-ubiquitination and proteasomal degradation of specific protein substrates, potentially leading to their deleterious accumulation. Here, we identify the molecular chaperones, Hsp70 and Hsc70, as substrates for parkin. Parkin mediates the ubiquitination of Hsp70 both in vitro and in cultured cells. Parkin interacts with Hsp70 via its second RING finger domain and mutations in/near this domain compromise Hsp70 ubiquitination. Ubiquitination of Hsp70 fails to alter its steady-state levels or turnover, nor does it promote its proteasomal degradation. Consistent with this observation, Hsp70 levels remain unaltered in brains from parkin-deficient autosomal recessive, juvenile-onset parkinsonism subjects, whereas alternatively, Hsp70 levels are elevated in the detergent-insoluble fraction of sporadic Parkinson's disease/dementia with Lewy bodies brains. Parkin mediates the multiple mono-ubiquitination of Hsp70/Hsc70 consistent with a degradation-independent role for this ubiquitin modification. Our observations support a novel functional relationship between parkin and Hsc/Hsp70 and support the notion that parkin is a multi-purpose E3 ubiquitin ligase capable of modifying proteins either via attachment of alternatively linked poly-ubiquitin chains or through multiple mono-ubiquitination to achieve alternate biological outcomes.

MeSH Terms
Aged Brain/enzymology,pathology,physiology Cell Line Cell Line, Tumor HSP70 Heat-Shock Proteins/genetics,metabolism Humans Parkinson Disease/genetics,metabolism,pathology Ubiquitin/genetics,metabolism Ubiquitin-Protein Ligases/genetics,physiology
Chemicals
HSP70 Heat-Shock Proteins Ubiquitin Ubiquitin-Protein Ligases parkin protein
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Moore Darren J
Institute for Cell Engineering, and Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA. djmoore@jhmi.edu
West Andrew B
Dikeman Dustin A
Dawson Valina L
Dawson Ted M
References (61)
61 references, click to expand
  1. Identification of far upstream element-binding protein-1 as an authentic Parkin substrate.
    J Biol Chem. 2006 Jun 16;281(24):16193-6 PMID: 16672220
  2. Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation.
    J Neurosci. 2005 Feb 23;25(8):2002-9 PMID: 15728840
  3. Complex relationship between Parkin mutations and Parkinson disease.
    Am J Med Genet. 2002 Jul 8;114(5):584-91 PMID: 12116199
  4. Ubiquitylation of BAG-1 suggests a novel regulatory mechanism during the sorting of chaperone substrates to the proteasome.
    J Biol Chem. 2002 Nov 29;277(48):45920-7 PMID: 12297498
  5. Alpha-synuclein and parkin contribute to the assembly of ubiquitin lysine 63-linked multiubiquitin chains.
    J Biol Chem. 2005 Apr 29;280(17):16619-24 PMID: 15718234
  6. The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI.
    Hum Mol Genet. 2003 Oct 15;12(20):2587-97 PMID: 12925569
  7. Novel monoclonal antibodies demonstrate biochemical variation of brain parkin with age.
    J Biol Chem. 2003 Nov 28;278(48):48120-8 PMID: 12972409
  8. Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity.
    J Biol Chem. 2000 Nov 17;275(46):35661-4 PMID: 10973942
  9. Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species.
    J Neurosci. 2006 Jun 28;26(26):6985-96 PMID: 16807328
  10. In vivo evidence of CHIP up-regulation attenuating tau aggregation.
    J Neurochem. 2005 Sep;94(5):1254-63 PMID: 16111477
  11. Parkin-mediated lysine 63-linked polyubiquitination: a link to protein inclusions formation in Parkinson's and other conformational diseases?
    Neurobiol Aging. 2006 Apr;27(4):524-9 PMID: 16213628
  12. Complete genomic screen in Parkinson disease: evidence for multiple genes.
    JAMA. 2001 Nov 14;286(18):2239-44 PMID: 11710888
  13. Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation.
    Nat Cell Biol. 2003 May;5(5):461-6 PMID: 12717448
  14. Molecular pathways of neurodegeneration in Parkinson's disease.
    Science. 2003 Oct 31;302(5646):819-22 PMID: 14593166
  15. Role for the ubiquitin-proteasome system in Parkinson's disease and other neurodegenerative brain amyloidoses.
    Neuromolecular Med. 2003;4(1-2):95-108 PMID: 14528055
  16. U-box protein carboxyl terminus of Hsc70-interacting protein (CHIP) mediates poly-ubiquitylation preferentially on four-repeat Tau and is involved in neurodegeneration of tauopathy.
    J Neurochem. 2004 Oct;91(2):299-307 PMID: 15447663
  17. Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress.
    Hum Mol Genet. 2005 Jan 1;14(1):71-84 PMID: 15525661
  18. Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1.
    Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13354-9 PMID: 11078524
  19. CHIP-mediated stress recovery by sequential ubiquitination of substrates and Hsp70.
    Nature. 2006 Mar 23;440(7083):551-5 PMID: 16554822
  20. Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: evidence for variable homozygous deletions in the Parkin gene in affected individuals.
    Ann Neurol. 1998 Dec;44(6):935-41 PMID: 9851438
  21. Genetics of Parkinson's disease and parkinsonism.
    Ann Neurol. 2006 Oct;60(4):389-98 PMID: 17068789
  22. Neurodegenerative tauopathies.
    Annu Rev Neurosci. 2001;24:1121-59 PMID: 11520930
  23. Polyubiquitin chains: polymeric protein signals.
    Curr Opin Chem Biol. 2004 Dec;8(6):610-6 PMID: 15556404
  24. S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function.
    Science. 2004 May 28;304(5675):1328-31 PMID: 15105460
  25. Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity.
    Neuron. 2003 Mar 6;37(5):735-49 PMID: 12628165
  26. Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity.
    Hum Mol Genet. 2006 Jul 1;15(13):2059-75 PMID: 16714300
  27. CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.
    J Biol Chem. 2004 Feb 6;279(6):4869-76 PMID: 14612456
  28. Genes and parkinsonism.
    Lancet Neurol. 2003 Apr;2(4):221-8 PMID: 12849210
  29. Accumulation of the authentic parkin substrate aminoacyl-tRNA synthetase cofactor, p38/JTV-1, leads to catecholaminergic cell death.
    J Neurosci. 2005 Aug 31;25(35):7968-78 PMID: 16135753
  30. CHIP is a U-box-dependent E3 ubiquitin ligase: identification of Hsc70 as a target for ubiquitylation.
    J Biol Chem. 2001 Nov 16;276(46):42938-44 PMID: 11557750
  31. Staging of brain pathology related to sporadic Parkinson's disease.
    Neurobiol Aging. 2003 Mar-Apr;24(2):197-211 PMID: 12498954
  32. Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.
    Hum Mol Genet. 2005 Sep 1;14(17):2571-86 PMID: 16049031
  33. The triage of damaged proteins: degradation by the ubiquitin-proteasome pathway or repair by molecular chaperones.
    FASEB J. 2006 Apr;20(6):741-3 PMID: 16469848
  34. Parkin-mediated monoubiquitination of the PDZ protein PICK1 regulates the activity of acid-sensing ion channels.
    Mol Biol Cell. 2007 Aug;18(8):3105-18 PMID: 17553932
  35. Mechanisms underlying ubiquitination.
    Annu Rev Biochem. 2001;70:503-33 PMID: 11395416
  36. A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)K-Akt signalling.
    Nat Cell Biol. 2006 Aug;8(8):834-42 PMID: 16862145
  37. CHIP promotes proteasomal degradation of familial ALS-linked mutant SOD1 by ubiquitinating Hsp/Hsc70.
    J Neurochem. 2004 Jul;90(1):231-44 PMID: 15198682
  38. An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin.
    Cell. 2001 Jun 29;105(7):891-902 PMID: 11439185
  39. Association between early-onset Parkinson's disease and mutations in the parkin gene.
    N Engl J Med. 2000 May 25;342(21):1560-7 PMID: 10824074
  40. Parkinson's disease. First of two parts.
    N Engl J Med. 1998 Oct 8;339(15):1044-53 PMID: 9761807
  41. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction.
    Physiol Rev. 2002 Apr;82(2):373-428 PMID: 11917093
  42. Genetics of parkin-linked disease.
    Hum Genet. 2004 Mar;114(4):327-36 PMID: 14727181
  43. CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation.
    Hum Mol Genet. 2004 Apr 1;13(7):703-14 PMID: 14962978
  44. SEPT5_v2 is a parkin-binding protein.
    Brain Res Mol Brain Res. 2003 Oct 7;117(2):179-89 PMID: 14559152
  45. The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration.
    Hum Mol Genet. 2003 Jun 15;12(12):1427-37 PMID: 12783850
  46. Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease.
    Nat Med. 2001 Oct;7(10):1144-50 PMID: 11590439
  47. Parkinson's disease. Second of two parts.
    N Engl J Med. 1998 Oct 15;339(16):1130-43 PMID: 9770561
  48. Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q.
    Neurology. 1998 Sep;51(3):890-2 PMID: 9748052
  49. Immunohistochemical and subcellular localization of Parkin protein: absence of protein in autosomal recessive juvenile parkinsonism patients.
    Ann Neurol. 1999 May;45(5):668-72 PMID: 10319893
  50. The ubiquitin-related BAG-1 provides a link between the molecular chaperones Hsc70/Hsp70 and the proteasome.
    J Biol Chem. 2000 Feb 18;275(7):4613-7 PMID: 10671488
  51. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17.
    Nature. 1998 Jun 18;393(6686):702-5 PMID: 9641683
  52. Recognition of the polyubiquitin proteolytic signal.
    EMBO J. 2000 Jan 4;19(1):94-102 PMID: 10619848
  53. CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity.
    Mol Cell. 2002 Jul;10(1):55-67 PMID: 12150907
  54. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease.
    Science. 2002 Feb 1;295(5556):865-8 PMID: 11823645
  55. Molecular pathophysiology of Parkinson's disease.
    Annu Rev Neurosci. 2005;28:57-87 PMID: 16022590
  56. Diverse effects of pathogenic mutations of Parkin that catalyze multiple monoubiquitylation in vitro.
    J Biol Chem. 2006 Feb 10;281(6):3204-9 PMID: 16339143
  57. Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin-like domain.
    EMBO Rep. 2003 Mar;4(3):301-6 PMID: 12634850
  58. Parkin binds to alpha/beta tubulin and increases their ubiquitination and degradation.
    J Neurosci. 2003 Apr 15;23(8):3316-24 PMID: 12716939
  59. Parkin: a multifaceted ubiquitin ligase.
    Biochem Soc Trans. 2006 Nov;34(Pt 5):749-53 PMID: 17052189
  60. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase.
    Nat Genet. 2000 Jul;25(3):302-5 PMID: 10888878
  61. Parkin ubiquitinates and promotes the degradation of RanBP2.
    J Biol Chem. 2006 Feb 10;281(6):3595-603 PMID: 16332688
Article Info
Journal
Journal of neurochemistry
Abbr.
J Neurochem
ISSN
1471-4159
Published
2008-06-00
Epub
2008-00-01
Pages
1806-19
Language
English
Region
England
NLM ID
2985190R
PMCID
PMC4432938
Subset
IM
Grants
NINDS NIH HHS · K99/R00 NS058111 · United States
NINDS NIH HHS · R01 NS048206 · United States
NINDS NIH HHS · R00 NS058111 · United States
NINDS NIH HHS · P50 NS38377 · United States
NINDS NIH HHS · P50 NS038377 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com